Dan Vulcanescu

PharmD | President of Global Biotech Revolution

Greater Paris Metropolitan Region

About

I am focused on building expertise in biotech dealmaking, investment, and venture building. PharmD with cross-sector experience across pharma, biotech, medtech, consulting, and banking in Europe and the US, spanning both operational and investment-facing environments. As President of Global Biotech Revolution, an international platform developing the next generation of biotech leaders, I lead initiatives and ecosystem partnerships at the intersection of science, education, and innovation. Alongside this, I support advisory work with pharmaceutical companies and investment funds on strategic topics in healthcare innovation and life sciences investing. I am particularly interested in how scientific innovation translates into healthcare solutions that improve patient outcomes while creating investable and scalable opportunities. Outside of work, I enjoy combining science, creativity, and music.

Experience

  • Founder at DAV Advisory
    Feb 2026 - Present · 5 mos

    DAV Advisory provides practical strategic and operational support to biotech and medtech companies, investment funds, and specialized life sciences advisory firms, helping them move forward on growth, partnerships, and funding decisions across European and US markets. https://davadvisory.com/

  • Global Biotech Revolution (2 yrs 1 mo)
    • President
      Jan 2026 - Present · 6 mos

      Global Biotech Revolution is an international non-profit dedicated to inspiring the next generation of biotech leaders through global community-building, talent development, and innovation in life sciences, connecting a network of 4,000+ alumni across 125 countries and bringing together leaders from pharma, biotech, and investment through international initiatives and summits.

    • Co-President
      Apr 2025 - Dec 2025 · 9 mos

    • Vice President
      Jun 2024 - Apr 2025 · 11 mos

  • M&A Analyst at Crédit Agricole CIB
    Jan 2024 - Jun 2024 · 6 mos

    Pharma & Healthcare team - Large cap

  • Consultant at Roland Berger
    Jul 2023 - Dec 2023 · 6 mos

    Pharma & Healthcare team

  • Business Analyst at Roche
    Apr 2022 - Aug 2022 · 5 mos

    Sales Force Effectiveness & Consumer experience team